Modulating immune cell fate and inflammation through CRISPR-mediated DNA methylation editing

Area of Science:

• Immunology
• Epigenetics
• Molecular Biology

Background:

• Immune cell differentiation and activation involve DNA methylation changes, but their causal role in cell fate is unclear.
• Understanding the link between DNA methylation and gene expression in immune cells is crucial for deciphering immune regulation.

Purpose of the Study:

• To investigate the genome-wide relationship between DNA methylation and gene expression in human immune cells.
• To establish a causal link between DNA methylation changes and immune cell function.

Main Methods:

• Genome-wide analysis of DNA methylation and gene expression in human immune cells.
• Utilized CRISPR-dCas9-TET1 and -DNMT3A epigenome editing tools for targeted DNA methylation modification.
• Focused on the promoter region of the interleukin-1 receptor antagonist (IL1RN) gene.

Main Results:

• Established a direct cause-and-effect relationship between IL1RN promoter DNA methylation levels and its gene expression.
• Demonstrated that modifying IL1RN promoter methylation alters human myeloid cell fate.
• Showed changes in cellular responses to inflammatory and pathogenic stimuli upon IL1RN methylation alteration.

Conclusions:

• Targeting specific DNA methylation events can directly modulate immune and inflammatory responses.
• Provides a proof of principle for therapeutic interventions in inflammation-related diseases by manipulating epigenetic modifications.
• Highlights the potential of epigenome editing for immune system modulation.